Rule Breaker Portfolio
Celera Genomics

Applera Corp--Celera Genomics (NYSE: CRA)
301 Merritt 7
Norwalk, CT 06851
http://www.celera.com

News

12/16/99: Buy Announcement
04/23/02: Sell Announcement

Buy Stats

On December 17, 1999 the Rule Breaker Portfolio bought 630 shares of bioinformatics company Celera Genomics (NYSE: CRA). The cost was $79.50 per share plus an $8.00 commission. For the full rationale behind this Rule Breaking purchase, please see the buy report.

ACTION  #  STOCK  PRICE  COMS'N  TOTAL COST
BOUGHT 630  CRA  $79.50    $8    $50,093.00
Sell Stats

On April 24, 2002, the Rule Breaker Portfolio sold all 1260 of its shares (after a 2:1 stock split) in Celera Genomics, filled as 100 at $16.64 a share and 1160 at $16.30 a share, plus an $8 commission. We lost 59% of our investment in Celera Genomics,  compared to a 23% loss in the S&P 500. For the rationale behind the sale, please see the sell report.

ACTION  #  STOCK  PRICE   COMS'N   PROCEEDS
SOLD   100  CRA  $16.64
SOLD   1160 CRA  $16.30    $8     $20,564.00